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Background and Objective.MEFV gene codes the pyrine protein that has major role in FMF as an autoinflammatory disorder. FMF
is more often seen in the people of the Mediterranean area. Considering the significant role ofMEFV gene in many rheumatologic
diseases and even nonrheumatologic disorders, it is necessary to identify different variations of these mutations in the healthy and
normal population of this area. Methods. 224 healthy (unaffected or control) people based on the Cochran formula entered this
study. The blood samples were screened for the 12 common MEFV gene variants polymorphisms according to manufacturer’s
instructions (FMF Strip Assay, Vienna lab, Vienna, Austria). They filled a questionnaire containing required information. All
healthy control cases initially were evaluated for FMF symptoms and signs in themselves and their first-degree relatives based
on clinical criteria. All data were analyzed by simple statistical method. Results. Among 224 healthy control cases, 113 (50.4%) were
male and 111 (49.6%) female. There wereMEFV variants alleles in 57 patients (25%): 28 were male (49.1%) and 29 female (50.9%).
The most frequent variants were E148Q (18.3%), followed by P369S (3.1%), V726A (2.2%), A744S (1.3%), and F479L, M694V, and
R761H (0.8%), and eventually K695R (0.4%), respectively. Some variants such as M694I, M680I (G/C), M680I (G/A), and I692del
were not seen in these samples. There were compound heterozygote variations of E148Q/P369S, E148Q/V726A, E148Q/P369S, and
P369S/F479L in normal populationwithout any findings in favor of FMF.Conclusion. Twenty-five percent of the normal populations
of the northwest of Iran are carryingMEFV gene variants, and themost commonmutation is E148Q (18.3%).Thepresence ofM694I,
M680I (G/C), M680I (G/A), I692del mutations in the normal population can be interpreted cautiously, while particular compound
heterozygote mutations can be considered as normal variants.
1. Introduction
FMF disease is a self-inflammatory autosomal recessive
genetic disorder inherited through the MEFV gene. FMF is
more often seen in the people of the Mediterranean coast,
Turkish breeds, Jews, Arabs, and Armenians. The prevalence
of this disease in high-risk populations is about 1-3 per 1,000,
and it is rare in other ethnic groups. The gene responsible for
the disease is theMEFV gene [1–3].
The location of this gene is on the chromosome 16 (P13.3).
MEFV gene encodes a protein, called Pyrin, which plays a
role in reducing inflammation. The inflammatory regulation
does not occur correctly in mutated condition. More than
342 sequence variants have already been identified onMEFV
gene [4–7].
FMF is characterized by recurrent fever and inflamma-
tion of the serous membranes, which causes abdominal pain,
joint inflammation, and chest pain. Some other diseases that
are characterized by inflammation of the blood vessels (vas-
culitis), such as Henoch-Scho¨nlein purpura and polyarteritis
nodosa, are more common in FMF patient. The most severe
complication in untreated patient is amyloidosis [8].
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Symptoms can be manifested in the first decade of life;
near 83% of the patients show the first signs of the disease
during childhood and adolescences [9, 10]. Diagnosis of
FMF is based on the Tel-Hashomer clinical criteria and
confirmation by MEFV gene mutations evaluation. Among
common polymorphismsM694V is one of the most frequent
variants and causes the most severe clinical features [11].
FMF is considered in the differential diagnosis of different
autoinflammatory syndromes and different studies discussed
about the possible role of the MEFV gene in PFAPA patients
[12].
Considering the importance of FMF and its significant
prevalence in the northwest of Iran, near Mediterranean
region [1], and the significant role of MEFV gene in many
rheumatologic diseases such as Behcet’s disease, PAN, HSP,
and even nonrheumatologic disorders [3], it is necessary
to identify different variations of this mutations in the
unaffected and normal population of this area, which is near
to Mediterranean Sea.
2. Methods
This descriptive cross-sectional study was conducted on peo-
ples over 40 years oldwhowere referred to the tertiary central
Hospital during two years for cardiovascular evaluations.
Including criteria were as follows:
(i) People over 40 years old.
(ii) Absence of FMFandperiodic fever symptoms in cases
and their first-degree relatives based on clinical and
genetic criteria.
(iii) Lack of rheumatologic diseases such as RA, Behcet’s
disease, and vasculitis in patients.
The number of samples is determined based on the Cochran
formula, as 224 subjects. Blood samples were screened for
the 12 common pathogenic variants (E148Q, P369S, F479L,
I692del, M680I(G/C), M680I(G/A), M694V, M694I, K695R,
V726A, A 744S, and R 761H) according to manufacturer’s
instructions (FMF Strip Assay, Vienna lab, Vienna, Austria).
Patients filled out a questionnaire containing complete
information of their past medical history including rheuma-
tologic disorder. All patients initially were examined and
evaluated for the FMF symptoms and presentations.
All data were analyzed by simple statistical method.
The study was approved by the faculty of Medicine Ethics
Committee and informed consent was obtained from all the
participants.
3. Results
From 224 samples 113 (50.4%) cases were male and 111
(49.6%) female. MEFV gene variants were detected in 57
cases (25%); among them 28 weremale (49.1%) and 29 female
(50.9%). There was not any correlation between sex and
MEFV mutations.
The most frequent variant was E148Q in 41 cases (18.3%),
followed by P369S with 7 cases (3.1%), V726A with 5 cases
(2.2%), A744S with 3 cases (1.3%), and F479L, M694V, and
Table 1: Frequency of variant alleles.
Variant Alleles No (%)
E148Q 41 (18.3)
P369S 7 (3.1)
V726A 5 (2.2)
A744S 3 (1.3)
F476L 2 (0.8)
M694V 2 (0.8)
R761H 2 (0.8)
K695R 1 (0.4)
R761H each of them with 2 cases (0.8%) and eventually only
1 case (0.4%) of the K695R mutation. M694I, M680I (G/C),
M680I (G/A), and I692del mutations were not seen in these
unaffected people (Table 1).
There were also some compound heterozygote variants
such as E148Q/P369S, E148Q/V726A, E148Q/P369S, and
P369S/F479L in normal population in this area. There
was significantly presence of P369S mutation in compound
asymptomatic heterozygote variants.
4. Discussion
This study showed 25% of MEFV gene variants in the
normal population of northwest of Iran, which is near to the
Mediterranean Sea and possesses high prevalence of FMF
disease.
In a study by Cos¸kun et al. [13], 220 patients with FMF
were comparedwith a group of 228 healthy people as a control
group. Five mutations of M694V, M694I, M680I, V726A,
R761H, and E148Q were determined. The E148Q mutation
similar to our study was found to be significantly higher in
the control group (10.5%).
Four cases had compound heterozygote mutations
(E148Q/P369S, E148Q/V726A, E148Q/P369S, and P369S/
F479L); none of them had symptoms of FMF and serositis
or other rheumatologic diseases. This emphasized the
numerous studies that occurrence of FMF is based on
genetic factors, but different environmental factors could
influence it [14].
In a study by Bonyadi et al., five MEFV mutations
(M694V, V726A, M680I, M694I, and E148Q) were examined
in 200 healthy people. They showed 25%mutation in normal
Azeri Turkish population. The most common mutation was
E148Q with 11.5% and subsequently V726A with 1.75 % [15].
Our study was carried out with examining 12 common
mutations and showed the same results with a higher percent-
age, E148Q mutation with 18.3%, and V726A mutation with
2.2%.
In a study by Ebadi et al., twelve common MEFV gene
mutations were examined in 390 FMF patients from all area
of Iran. 234 patients (60%) had at least one mutation, and
156 patients (40%) were without any common mutations.
The most common variants were M694V (13.6%), followed
by E148Q (10.4%), M694I (6.5%), V726A (4.1%), and M680I
(3.8%), respectively [16].
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Table 2: Comparison of patients and normal populations.
Variant Alleles FMF Normal
patients populations
M694V 23.6% 0.8%
V726A 11.1% 2.2%
E148Q 9.9% 18.3%
M680I 9% -
R761H 3.4% 0.8
M694I 3% -
In the study of Salehzadeh et al. [1], twelve common
MEFV gene mutations in 216 patients with FMF in the
northwest of Iran were examined; the most common alleles
wereM694V (23.6%), V726A (11.1%), and E148Q (9.9%).This
study in the normal population of the same region represents
an entirely different genotype of the patients and normal
population (Table 2).
It can be concluded that if E148Q mutation is seen in an
individual without FMF symptoms, it should be considered
as a normal variant rather than being a pathologic mutation
associated with FMF disease.
In this area the presence of M680I (G/C), M680I
(G/A), I692del, and M694I variants in asymptomatic peo-
ple should be interpreted with caution and considered in
favor of disease, particularly in suspected cases; more-
over, the E148Q/P369S, E148Q/V726A, E148Q/P369S, and
P369S/F479L compound heterozygote variants could be
interpreted as normal variants, even with two types of
compound heterozygote variants.
5. Conclusion
Twenty-five percent of the normal populations of the north-
west of Iran have MEFV gene variants alleles and the most
common variant is E148Q (18.3%). It seems M694I, M680I
(G/C), M680I (G/A), and I692del mutations are not a normal
population variants.
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